Vysis Gaining Oncor's Non-Oncology FISH Genetic Probe Business
This article was originally published in The Gray Sheet
Executive Summary
Vysis will receive Oncor's non-oncology fluorescence in situ hybridization (FISH) genetic probe business under the terms of an agreement to settle a patent infringement lawsuit between the two firms.